相关实验视频

Updated: Sep 10, 2025

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation

Published on: September 6, 2024

黑色素瘤治疗中的PARP抑制剂:潜力,挑战和未来方向

Angela Anaeme¹, Karen Moussa², Abdallah N Mansour³

¹Division of Medical Oncology, Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, MO, United States.

Frontiers in oncology

|August 22, 2025

概括

通过向DNA修复缺陷来治疗黑色素瘤,PARP抑制剂显得有前途. 进一步的研究正在研究晚期和转移性黑色素瘤的临床试验中的有效性和安全性.

科学领域:

癌症学
分子生物学
遗传学

背景情况:

基因组完整性对于细胞的稳定性至关重要; 缺陷导致癌症.
同源重组缺陷 (HRD) 损害了DNA修复,导致细胞功能障碍.
聚氨酸- 核糖酶 (PARP) 抑制剂向DNA修复途径.

研究的目的:

审查PARP抑制剂在黑色素瘤治疗中的有用性.
讨论目前在黑色素瘤中研究PARP抑制剂的临床试验.
探索PARP抑制剂在黑色素瘤中的未来研究方向.

主要方法:

在癌症治疗中对PARP抑制剂的文献审查.
对PARP抑制剂在HRD相关瘤中的有效性现有数据的分析.
检查正在进行的黑色素瘤治疗临床试验.

主要成果:

PARP 抑制剂是乳腺癌,卵巢癌,胰腺癌和前列腺癌的已知治疗方法.
对PARP抑制剂在黑色素瘤中的疗效的证据较少,但越来越多.
目前正在进行的试验研究PARP抑制剂作为单一治疗和结合治疗黑色素瘤.

结论:

在晚期和转移性黑色素瘤中,PARP抑制剂是潜在的治疗策略.
需要进一步研究以充分了解PARP抑制剂在黑色素瘤中的有效性和安全性.
涉及PARP抑制剂的组合疗法对黑色素瘤治疗具有前景.

关键词:

抑制PARP的药物皮肤黑色素瘤同类重组缺陷黑色素瘤合成杀伤性

更多相关视频

A 3D Organotypic Melanoma Spheroid Skin Model

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...